We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > INDICAID

News List

INDICAID(TM) COVID-19 Rapid Antigen Test Receives Emergency Use Authorization From the U.S. Food and Drug Administration prnasia
August 11, 2021
PHASE Scientific International LTD (PHASE Scientific), today announced that its INDICAID™ COVID-19 Rapid Antigen Test (INDICAID) received Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA) on July 29, 2021.
INDICAID(R) COVID-19 Rapid Antigen Test certified by Cambodia's Ministry of Health for Disease Control prnasia
June 22, 2021
Cambodia's Ministry of Health has approved INDICAID® COVID-19 Rapid Antigen Test for commercialisation as part of the country's efforts in controlling recent spikes of COVID-19 cases in the region.
Hong Kong, S.A.R., China government endorses INDICAID(R) in visitation resumption arrangements prnasia
May 10, 2021
COVID-19 rapid antigen test (RAT) INDICAID®, developed by Hong Kong, S.A.R., China biotechnology start-up PHASE Scientific International Limited (PHASE), has been named by the government as one of the designated rapid tests when care homes resume visitati